You are here:Home-Chemical Inhibitors & Agonists-Nuclear Receptor/Transcription Factor-PPAR-SR-1664
SR-1664

Chemical Structure : SR-1664

CAS No.: 1338259-05-4

SR-1664 (SR 1664;SR1664)

Catalog No.: PC-60333Not For Human Use, Lab Use Only.

A novel potent, non-agonist PPARγ ligand that blocks the Cdk5-mediated phosphorylation in vitro (IC50=80 nM) and in vivo, without the classical agonism.

Packing Price Stock Quantity

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC)

Biological Activity

A novel potent, non-agonist PPARγ ligand that blocks the Cdk5-mediated phosphorylation in vitro (IC50=80 nM) and in vivo, without the classical agonism; exhibits potent anti-diabetic activity while not causing the fluid retention and weight gain that are serious side effects of many of the PPARγ drugs; effectively improves glucose homeostasis, and does not affect bone cell mineralization in culture.

Physicochemical Properties

M.Wt 547.6
Formula C33H29N3O5
Appearance Solid
CAS No.
Storage
Solide Powder
-20 °C 12 Months; 4°C 6 Months
In Solvent
-80 °C 6 Months; -20°C 6 Months
Shipping
Solubility

100 mM in DMSO

Chemical Name/SMILES

4'-[[2,3-Dimethyl-5-[[[(1S)-1-(4-nitrophenyl)ethyl]amino]carbonyl]-1H-indol-1-yl]methyl]-[1,1'-biphenyl]-2-carboxylic acid

References

1. Choi JH, et al. Nature. 2011 Sep 4;477(7365):477-81.

2. Choi SS, et al. J Biol Chem. 2014 Sep 19;289(38):26618-29.

3. Marciano DP, et al. Nat Commun. 2015 Jun 12;6:7443.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: